Cita APA

Franco-Mateos, E., Souza-Egipsy, V., García-Estévez, L., Pérez-García, J., Gion, M., Garrigós, L., . . . Vega, J. F. (2024). Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer.

Citación estilo Chicago

Franco-Mateos, Emma, et al. Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab Versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer. 2024.

Cita MLA

Franco-Mateos, Emma, et al. Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab Versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer. 2024.